MedTrace Logo

Thulium Laser Versus Bipolar Enucleation of the Prostate

NCT05200065 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-01-20

No results posted yet for this study

Summary

Comparing the peri-operative outcomes in patients with benign prostatic hyperplasia (BPH) who will undergo bipolar enucleation of the prostate versus thulium laser enucleation.

Conditions

  • Benign Prostatic Hyperplasia

Interventions

PROCEDURE

Thulium laser enucleation of the prostate

Using the thulium laser to achieve complete endoscopic enucleation of the prostate.

PROCEDURE

Bipolar enucleation of the prostate

Using the bipolar plasma energy to achieve complete endoscopic enucleation of the prostate.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Omar AbdelRazzak, MD Urology · Kasr AlAiny

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2022-07-31
Completion
2022-10-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05200065 on ClinicalTrials.gov